Here, using IHC of healthy and cancer tissue arrays and quantitative analysis, we demonstrate that the levels of TSPO were 10-fold higher in brains from patients with GBM than in healthy tissue (Figure 5A). This evidence concerns the gene TSPO and glioblastoma.